Fulvestrant (Page 7 of 7)
Principal Display Panel – Syringe Label
NDC 0143-9022 -01 Rx only
Fulvestrant Injection
250 mg per 5 mL (50 mg per mL)
For Intramuscular Use ONLY
PROTECT FROM LIGHT
Both single-dose prefilled syringes must be administered to receive the 500 mg dose.
Principal Display Panel — Carton with Serialization Placeholder
NDC 0143-9022 -02 Rx only
Fulvestrant Injection
250 mg per 5 mL (50 mg per mL)
For Intramuscular Use ONLY
Contains 2 single-dose prefilled syringes
FULVESTRANT fulvestrant injection | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Hikma Pharmaceuticals USA Inc. (001230762) |
Registrant — Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (547876677) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 421304996 | analysis (0143-9022), label (0143-9022), manufacture (0143-9022), pack (0143-9022) |
Revised: 06/2022 Hikma Pharmaceuticals USA Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.